Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GW Pharmaceuticals PLC (NASDAQ:GWPH)

91.57
Delayed Data
As of Jun 30
 -1.64 / -1.76%
Today’s Change
35.83
Today|||52-Week Range
131.25
+31.87%
Year-to-Date

Today’s Trading

Previous close93.21
Today’s open93.26
Day’s range89.27 - 94.66
Volume514,358
Average volume (3 months)697,727
Market cap$2.0B
Dividend yield--
Data as of 06/30/2016

Growth & Valuation

Earnings growth (last year)-140.06%
Earnings growth (this year)-69.72%
Earnings growth (next 5 years)-42.61%
Revenue growth (last year)-11.81%
P/E ratio--
Price/Sales42.63
Price/Book5.46

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV+1.29+2.38%
RAREUltragenyx Pharmaceu...-0.84-1.69%
MYGNMyriad Genetics Inc+0.03+0.10%
IPXLImpax Laboratories I...-0.31-1.06%
Data as of 06/30/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$1.61
Annual revenue (last year)$44.0M
Annual profit (last year)-$68.7M
Net profit margin-156.14%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Justin D. Gover
Chief Operating Officer &
Executive Director
Christopher John Tovey
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts

Partner Offers

Search for Jobs